C.M. Bidwell & Associates’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-436
Closed -$1.78K 554
2024
Q2
$1.78K Buy
+436
New +$1.78K ﹤0.01% 415